If the buy interest lately is a omen of things to come there may be positives moving forward. Hard to pinpoint what will be the catalyst. Both adenosine and thapsigargin based drug platforms are possible candidates and with the capability of microparticle technology for both platforms a substantial event my surface from either/or drugs.
News 
Market Data 
Discover 
